Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1P5, or "UBE2V1 pseudogene 5", is a pseudogene related to the canonical UBE2V1 gene, which encodes ubiquitin-conjugating enzyme E2 variant 1. UBE2V1P5 does not encode a functional protein and is not recognized as a therapeutic target. UBE2V1P5 (UBE2V1 pseudogene 5) is a human pseudogene related to the UBE2V1 family located on chromosome 20[3]. As a pseudogene, UBE2V1P5 contains sequence similarity to the active UBE2V1 gene but does not encode a functional protein and has no enzymatic or structural function in the cell. It is not involved in known disease pathways, does not serve as a clinical biomarker or drug target, and does not play a direct role in biological processes or disease[3]. It is distinct from the functional UBE2V1 gene, which catalyzes Lys-63-linked polyubiquitination and has established roles in immune response, DNA repair, and cell signaling[1][2][5][8]. Note: If your intent is to refer to the druggable E2 enzyme protein, you should instead use "Ubiquitin-conjugating enzyme E2 variant 1" (UBE2V1), not UBE2V1P5, which is a non-functional pseudogene[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2V1 pseudogene 5 (UBE2V1P5).